Application 205834
- Type
- NDA
- Sponsor
- GILEAD SCIENCES INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HARVONI | LEDIPASVIR; SOFOSBUVIR | TABLET;ORAL | 90MG;400MG | Yes | Yes |
| 002 | HARVONI | LEDIPASVIR; SOFOSBUVIR | TABLET;ORAL | 45MG;200MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205834-001 | HARVONI | LEDIPASVIR; SOFOSBUVIR | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | |
| N205834-002 | HARVONI | LEDIPASVIR; SOFOSBUVIR | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N205834-001 | 8334270 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 8580765 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 8735372 | 2028-03-21 | U-1470 | 2014-10-30 | |
| N205834-001 | 9085573 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2015-08-11 |
| N205834-001 | 8334270*PED | 2028-09-21 | Pediatric extension | ||
| N205834-001 | 8580765*PED | 2028-09-21 | Pediatric extension | ||
| N205834-001 | 8735372*PED | 2028-09-21 | Pediatric extension | ||
| N205834-001 | 9085573*PED | 2028-09-21 | Pediatric extension | ||
| N205834-001 | 7964580 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 8633309 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 8889159 | 2029-03-26 | U-1470 | Drug product | 2014-12-11 |
| N205834-001 | 7964580*PED | 2029-09-26 | Pediatric extension | ||
| N205834-001 | 8633309*PED | 2029-09-26 | Pediatric extension | ||
| N205834-001 | 8889159*PED | 2029-09-26 | Pediatric extension | ||
| N205834-001 | 8088368 | 2030-05-12 | Drug substance, Drug product | 2014-10-30 | |
| N205834-001 | 8273341 | 2030-05-12 | U-1470 | 2014-10-30 | |
| N205834-001 | 8822430 | 2030-05-12 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 8841278 | 2030-05-12 | U-1470 | Drug product | 2014-10-30 |
| N205834-001 | 9511056 | 2030-05-12 | U-1470 | Drug product | 2017-01-05 |
| N205834-001 | 9284342 | 2030-09-13 | U-1470 | Drug substance, Drug product | 2016-04-12 |
| N205834-001 | 8088368*PED | 2030-11-12 | Pediatric extension | ||
| N205834-001 | 8273341*PED | 2030-11-12 | Pediatric extension | ||
| N205834-001 | 8822430*PED | 2030-11-12 | Pediatric extension | ||
| N205834-001 | 8841278*PED | 2030-11-12 | Pediatric extension | ||
| N205834-001 | 9511056*PED | 2030-11-12 | Pediatric extension | ||
| N205834-001 | 8618076 | 2030-12-11 | U-1470 | Drug substance, Drug product | 2014-10-30 |
| N205834-001 | 9284342*PED | 2031-03-13 | Pediatric extension | ||
| N205834-001 | 8618076*PED | 2031-06-11 | Pediatric extension | ||
| N205834-001 | 10456414 | 2032-09-14 | Drug product | 2019-11-20 | |
| N205834-001 | 9393256 | 2032-09-14 | U-1470 | 2016-08-15 | |
| N205834-001 | 9393256*PED | 2033-03-14 | Pediatric extension | ||
| N205834-001 | 10039779 | 2034-01-30 | U-2369 | Drug substance, Drug product | 2018-08-29 |
| N205834-001 | 10039779 | 2034-01-30 | U-2370 | Drug substance, Drug product | 2018-08-29 |
| N205834-001 | 10039779*PED | 2034-07-30 | Pediatric extension | ||
| N205834-002 | 8334270 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8580765 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8735372 | 2028-03-21 | U-1470 | 2019-09-23 | |
| N205834-002 | 9085573 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8334270*PED | 2028-09-21 | Pediatric extension | ||
| N205834-002 | 8580765*PED | 2028-09-21 | Pediatric extension | ||
| N205834-002 | 8735372*PED | 2028-09-21 | Pediatric extension | ||
| N205834-002 | 9085573*PED | 2028-09-21 | Pediatric extension | ||
| N205834-002 | 7964580 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8633309 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8889159 | 2029-03-26 | U-1470 | Drug product | 2019-09-23 |
| N205834-002 | 7964580*PED | 2029-09-26 | Pediatric extension | ||
| N205834-002 | 8633309*PED | 2029-09-26 | Pediatric extension | ||
| N205834-002 | 8889159*PED | 2029-09-26 | Pediatric extension | ||
| N205834-002 | 8088368 | 2030-05-12 | Drug substance, Drug product | 2019-09-23 | |
| N205834-002 | 8273341 | 2030-05-12 | U-1470 | 2019-09-23 | |
| N205834-002 | 8822430 | 2030-05-12 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8841278 | 2030-05-12 | U-1470 | Drug product | 2019-09-23 |
| N205834-002 | 9511056 | 2030-05-12 | U-1470 | 2019-09-23 | |
| N205834-002 | 9284342 | 2030-09-13 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 8088368*PED | 2030-11-12 | Pediatric extension | ||
| N205834-002 | 8273341*PED | 2030-11-12 | Pediatric extension | ||
| N205834-002 | 8822430*PED | 2030-11-12 | Pediatric extension | ||
| N205834-002 | 8841278*PED | 2030-11-12 | Pediatric extension | ||
| N205834-002 | 9511056*PED | 2030-11-12 | Pediatric extension | ||
| N205834-002 | 8618076 | 2030-12-11 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 9284342*PED | 2031-03-13 | Pediatric extension | ||
| N205834-002 | 8618076*PED | 2031-06-11 | Pediatric extension | ||
| N205834-002 | 10456414 | 2032-09-14 | Drug product | 2019-11-20 | |
| N205834-002 | 9393256 | 2032-09-14 | U-1470 | 2019-09-23 | |
| N205834-002 | 9393256*PED | 2033-03-14 | Pediatric extension | ||
| N205834-002 | 10039779 | 2034-01-30 | U-1470 | Drug substance, Drug product | 2019-09-23 |
| N205834-002 | 10039779*PED | 2034-07-30 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N205834-001 | ODE* | 2026-08-28 |
| N205834-002 | ODE* | 2026-08-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N205834-001 | HARVONI | 90MG;400MG | TABLET / ORAL | RLD, RS | 2014-10-10 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N205834-002 | HARVONI | 45MG;200MG | TABLET / ORAL | RLD | 2019-08-28 | 74a2ff9319b5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8334270 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8580765 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8735372 | 2028-03-21 | U-1470 | 2014-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9085573 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2015-08-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8334270*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8580765*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8735372*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9085573*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 7964580 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8633309 | 2029-03-26 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8889159 | 2029-03-26 | U-1470 | Drug product | 2014-12-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 7964580*PED | 2029-09-26 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8633309*PED | 2029-09-26 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8889159*PED | 2029-09-26 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8088368 | 2030-05-12 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8273341 | 2030-05-12 | U-1470 | 2014-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8822430 | 2030-05-12 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8841278 | 2030-05-12 | U-1470 | Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9511056 | 2030-05-12 | U-1470 | Drug product | 2017-01-05 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9284342 | 2030-09-13 | U-1470 | Drug substance, Drug product | 2016-04-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8088368*PED | 2030-11-12 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8273341*PED | 2030-11-12 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8822430*PED | 2030-11-12 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8841278*PED | 2030-11-12 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9511056*PED | 2030-11-12 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8618076 | 2030-12-11 | U-1470 | Drug substance, Drug product | 2014-10-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9284342*PED | 2031-03-13 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 8618076*PED | 2031-06-11 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 10456414 | 2032-09-14 | Drug product | 2019-11-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9393256 | 2032-09-14 | U-1470 | 2016-08-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 9393256*PED | 2033-03-14 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 10039779 | 2034-01-30 | U-2369 | Drug substance, Drug product | 2018-08-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 10039779 | 2034-01-30 | U-2370 | Drug substance, Drug product | 2018-08-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | 10039779*PED | 2034-07-30 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 8334270 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 8580765 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 8735372 | 2028-03-21 | U-1470 | 2019-09-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 9085573 | 2028-03-21 | U-1470 | Drug substance, Drug product | 2019-09-23 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 8334270*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | 8580765*PED | 2028-09-21 | Pediatric extension | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N205834-001 | ODE* | 2026-08-28 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N205834-002 | ODE* | 2026-08-28 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N205834-001 | ODE* | 2026-08-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205834-002 | ODE* | 2026-08-28 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205834-001 | ODE* | 2026-08-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205834-002 | ODE* | 2026-08-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205834-001 | ODE* | 2026-08-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205834-002 | ODE* | 2026-08-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N205834-001 | ODE* | 2026-08-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205834-002 | ODE* | 2026-08-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205834-001 | ODE* | 2026-08-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205834-002 | ODE* | 2026-08-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205834-001 | ODE* | 2026-08-28 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205834-002 | ODE* | 2026-08-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-001 | ODE-136 | 2024-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-001 | PED | 2024-10-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-001 | ODE* | 2026-08-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-002 | ODE* | 2024-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-002 | PED | 2024-10-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205834-002 | ODE* | 2026-08-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-001 | ODE-136 | 2024-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-001 | PED | 2024-10-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-001 | ODE* | 2026-08-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-002 | ODE* | 2024-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-002 | PED | 2024-10-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205834-002 | ODE* | 2026-08-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-001 | ODE-136 | 2024-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-001 | PED | 2024-10-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-001 | ODE* | 2026-08-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-002 | ODE* | 2024-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-002 | PED | 2024-10-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205834-002 | ODE* | 2026-08-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-001 | ODE-136 | 2024-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-001 | PED | 2024-10-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-001 | ODE* | 2026-08-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-002 | ODE* | 2024-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-002 | PED | 2024-10-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205834-002 | ODE* | 2026-08-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N205834-001 | ODE-136 | 2024-04-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205834-001 | PED | 2024-10-07 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ledipasvir and Sofosbuvir | LEDIPASVIR AND SOFOSBUVIR | Asegua Therapeutics LLC | 46f4a73b-0cd6-4902-9092-3ac79e882c1a | 2025-01-10 | Boxed warning, Warnings, Adverse reactions | 205834 NDA205834 72626-2601 |
| Harvoni | LEDIPASVIR AND SOFOSBUVIR | Gilead Sciences, Inc | f4ec77e4-bae8-4db0-b3d5-bde09c5fa075 | 2024-12-26 | Boxed warning, Warnings, Adverse reactions | 205834 NDA205834 61958-1803 61958-1801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1801 | Harvoni | LEDIPASVIR and SOFOSBUVIR | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 61958-1803 | Harvoni | ledipasvir and sofosbuvir | Gilead Sciences, Inc | NDA | Current |
| 72626-2601 | Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | Asegua Therapeutics LLC | NDA AUTHORIZED GENERIC | Current |
| 72626-2601 | Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | Asegua Therapeutics LLC | NDA AUTHORIZED GENERIC | Current |
| 72626-2601 | Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | Asegua Therapeutics LLC | NDA AUTHORIZED GENERIC | Current |
| 72626-2601 | Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | Asegua Therapeutics LLC | NDA AUTHORIZED GENERIC | Current |
| 72626-2601 | Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | Asegua Therapeutics LLC | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80685 | SUPPL | 2024-12-23 |
| 80666 | SUPPL | 2024-12-20 |
| 62079 | SUPPL | 2020-03-09 |
| 62074 | SUPPL | 2020-03-06 |
| 60967 | SUPPL | 2019-11-19 |
| 60887 | SUPPL | 2019-11-19 |
| 60068 | SUPPL | 2019-09-20 |
| 60060 | SUPPL | 2019-09-20 |
| 59885 | SUPPL | 2019-08-30 |
| 59872 | SUPPL | 2019-08-29 |
| 50393 | SUPPL | 2017-11-13 |
| 50375 | SUPPL | 2017-11-13 |
| 47980 | SUPPL | 2017-04-12 |
| 47920 | SUPPL | 2017-04-10 |
| 47218 | SUPPL | 2017-02-15 |
| 47213 | SUPPL | 2017-02-15 |
| 40513 | SUPPL | 2016-06-13 |
| 32744 | SUPPL | 2016-06-09 |
| 32745 | SUPPL | 2016-03-31 |
| 40514 | SUPPL | 2016-03-30 |
| 44934 | SUPPL | 2016-03-03 |
| 44933 | SUPPL | 2016-03-03 |
| 24508 | SUPPL | 2016-03-03 |
| 40512 | SUPPL | 2016-02-25 |
| 40511 | SUPPL | 2016-02-25 |
| 19690 | SUPPL | 2016-02-25 |
| 32743 | SUPPL | 2016-02-16 |
| 10514 | SUPPL | 2016-02-16 |
| 10513 | SUPPL | 2016-02-16 |
| 40510 | SUPPL | 2015-11-19 |
| 40509 | SUPPL | 2015-11-19 |
| 40508 | SUPPL | 2015-11-19 |
| 40507 | SUPPL | 2015-11-19 |
| 19689 | SUPPL | 2015-11-19 |
| 32742 | SUPPL | 2015-11-16 |
| 32741 | SUPPL | 2015-11-16 |
| 10512 | SUPPL | 2015-11-16 |
| 10511 | SUPPL | 2015-11-16 |
| 10510 | SUPPL | 2015-11-16 |
| 40506 | SUPPL | 2015-03-24 |
| 32740 | SUPPL | 2015-03-24 |
| 44932 | ORIG | 2014-11-03 |
| 43504 | ORIG | 2014-11-03 |
| 40505 | ORIG | 2014-10-15 |
| 10509 | ORIG | 2014-10-14 |
| 64115 | ORIG | 1900-01-01 |
| 64114 | ORIG | 1900-01-01 |
| 64113 | ORIG | 1900-01-01 |
| 64112 | ORIG | 1900-01-01 |
| 51287 | SUPPL | 1900-01-01 |
| 51286 | SUPPL | 1900-01-01 |
| 51285 | SUPPL | 1900-01-01 |